In the TME, various chemokines can be secreted by tumor, immune, and stromal cells, which ultimately activate multiple signal pathways via cell surface receptors and recruit immune cell subgroups to the TME, thereby spatiotemporally regulating the tumor immune response. This evidence concerns the gene CD177 and neoplasm.